Richard Jennelle, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Dr. Richard Jennelle is a board-certified radiation oncologist based in Los Angeles, California. He graduated from the University of Cincinnati College of Medicine and then did his internship at the Good Samaritan Hospital. He completed his residency in Internal Medicine at the Jewish Hospital of Cincinnati and also did a residency in Radiation Oncology at the University Hospital –University of Cincinnati College of Medicine. Dr. Jennelle has more than 20 years of clinical experience and is currently affiliated with multiple hospitals including the Keck Medical Center of USC, University of Arizona Medical Center, and USC Norris Cancer Hospital. He has also contributed to several research publications.
University of Cincinnati College of Medicine
Medical School
Good Samaritan Hospital
Internship
Jewish Hospital of Cincinnati
Residency
University Hospital - University of Cincinnati College of Medicine
Residency
American Board of Radiology - Radiation Oncology
Banner University Medical Center Tucson
Languages: English/Spanish
(520) 694-8888
1501 N Campbell Ave
Read MoreKeck Hospital of USC - Medical Center
Languages: English/Spanish
(323) 442-8500
1500 San Pablo St
Read MoreUSC Norris Comprehensive Cancer Center
Languages: English/Spanish
(323) 865-3000
1441 Eastlake Avenue
Read MoreComputerized tomography-based radiotherapy improves heterotopic ossification outcomes.
Mourad, W. F.,Packianathan, S.,Ma, J. K.,Yang, C. C.,Shourbaji, R. A.,He, R.,Zhang, Z.,Kanakamedala, M. R.,Khan, M. A.,Mobit, P.,Katsoulakis, E.,Nabhani, T.,Jennelle, ...; Bone. 2013 Nov.
See more >>The influence of pregnancy on heterotopic ossification post-displaced acetabular fractures surgical repair.
Mourad, W. F.,Packianathan, S.,Shourbaji, R. A.,Jennelle, R.,Yang, C. C.,Mobit, P.,Zhang, Z.,Khan, M. A.,Graves, M.,Russell, G.,Vijayakumar, S.; J Orthop Res. 2013 Jun.
See more >>Induction Docetaxel, Cisplatin, and 5-Fluorouracil Precludes Definitive Chemoradiotherapy in a Substantial Proportion of Patients With Head and Neck Cancer in a Low So...
Caudell, J. J.,Hamilton, R. D.,Otto, K. J.,Jennelle, R. L.,Pitman, K. T.,Vijayakumar, S.; Am J Clin Oncol. 2012 Dec 27.
See more >>